COMPANY NEWS


BSE Code ISIN Demat Book Value (₹) NSE Symbol Div & Yield % Market Cap ( Cr.) P/E * EPS * Face Value (₹)
* Profit to Earning Ratio
* Earning Per Share
Board of Dishman Pharmaceuticals and Chemicals considers High Court order sanctioning scheme of arra Back
(17 Mar 2017)
Dishman Pharmaceuticals and Chemicals announced that the Board of Directors of the Company at its meeting held on 17 March 2017 considered and took on record the Order of Hon'ble High Court of Gujarat, sanctioning the Scheme of Arrangement and Amalgamation amongst Dishman Pharmaceuticals and Chemicals, Carbogen Amcis (India) and Dishman Care and their respective Shareholders & Creditors, in which following decisions were also taken by the Board of Directors of the Company:

It was decided to sell Investment made by the Company in its following Associate and group companies to the promoter directors of the Company as part of restructuring process and to consolidate its investment made in entities without any material activities or loss making entities including Dishman Biotech, Bhadra-Raj Holding, Dishman Infrastructure and B R Laboratories.